Creative Medical Technology Holdings, Inc.
NASDAQ Capital MarketTotal Valuation
Creative Medical Technology Holdings, Inc. carries a market capitalization of 1.87M, placing it among publicly traded companies globally. Its enterprise value stands at -1.94M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 1.87M |
| Enterprise Value | -1.94M |
Share Statistics
Creative Medical Technology Holdings, Inc. currently has 4.74M shares outstanding.
| Shares Outstanding | 4.74M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
The price-to-sales ratio is 1,608.51, and the price-to-book ratio stands at 0.79.
| PE Ratio | N/A |
| PS Ratio | 1,608.51 |
| PB Ratio | 0.79 |
| P/TBV Ratio | 0.83 |
| P/FCF Ratio | -0.84 |
| P/OCF Ratio | -0.82 |
Enterprise Valuation
| EV / Sales | 1,140.94 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | N/A |
Financial Position
Creative Medical Technology Holdings, Inc. maintains a current ratio of 12.91, meaning it holds 12.9x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 12.91 |
| Quick Ratio | 12.81 |
| Debt / Equity | N/A |
| Debt / EBITDA | N/A |
| Interest Coverage | N/A |
Financial Efficiency
| Return on Equity (ROE) | -78.03 |
| Return on Assets (ROA) | -73.30 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 2.00 |
Stock Price Statistics
Creative Medical Technology Holdings, Inc.'s stock has declined approximately -79.95568% over the past 52 weeks. The 50-day moving average sits at 1.01, while the 200-day moving average is 1.64.
| Beta (5Y) | N/A |
| 52-Week Price Change | -79.95568% |
| 50-Day Moving Average | 1.01 |
| 200-Day Moving Average | 1.64 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Creative Medical Technology Holdings, Inc. generated 3,000.00 in revenue and converted that into -6.04M in net income, yielding earnings per share of -1.81. EBITDA reached -6.13M, while operating income came in at -6.24M.
| Revenue | 3,000.00 |
| Gross Profit | 2,006.00 |
| Operating Income | -6.24M |
| Pretax Income | -6.04M |
| Net Income | -6.04M |
| EBITDA | -6.13M |
| EBIT | -6.24M |
| Earnings Per Share (EPS) | -1.81 |
Balance Sheet
Total book value stands at 8.65M, with working capital of 8.32M providing operational flexibility.
| Cash & Cash Equivalents | 8.84M |
| Total Debt | N/A |
| Net Debt | -8.71M |
| Equity (Book Value) | 8.65M |
| Book Value Per Share | 1.83 |
| Working Capital | 8.32M |
Cash Flow
Creative Medical Technology Holdings, Inc. produced -5.90M in operating cash flow over the past twelve months. After subtracting -125,000.00 in capital expenditures, free cash flow totaled -6.03M - equivalent to -1.81 per share.
| Operating Cash Flow | -5.90M |
| Capital Expenditures | -125,000.00 |
| Free Cash Flow | -6.03M |
| FCF Per Share | -1.81 |
Margins
Creative Medical Technology Holdings, Inc. operates with a gross margin of 66.87, reflecting its pricing power and cost economics. The operating margin of -208,004.40 and net profit margin of -201,355.37 provide insight into operational efficiency.
| Gross Margin | 66.87 |
| Operating Margin | -208,004.40 |
| Pretax Margin | -201,285.83 |
| Profit Margin | -201,355.37 |
| EBITDA Margin | -204,211.70 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -120.69 |
| FCF Yield | -119.71 |
Stock Splits
Creative Medical Technology Holdings, Inc.'s most recent stock split took place on June 12, 2023 with a 10:1 split ratio.
| Last Split Date | 6/12/2023 |
| Split Ratio | 10:1 |
Scores
Creative Medical Technology Holdings, Inc. posts an Altman Z-Score of -6.68, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -6.68 |